| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| KRYS | Krystal Biotech, Inc. | Director | $410K | Jun 30, 2025 | ||
| RVNC | Revance Therapeutics, Inc. | Director | $0 | Feb 4, 2025 | ||
| OTLK | Outlook Therapeutics, Inc. | Director | Oct 1, 2025 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|